Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)

被引：2
|
作者：
Cervera, J. [1 ]
Sole, F.
Haase, D.
Luno, E.
Such, E.
Nomdedeu, B.
Costa, D.
Bernal, T.
Vallespi, T.
Bueno, J.
Pedro, C.
Mallo, M.
Ardanaz, M. T.
Calasanz, M. J.
del Canizo, C.
Hernandez-Rivas, J. M.
Schanz, J.
Steidl, C.
Hildebrandt, B.
Carbonell, F.
Orero, M.
Ramos, F.
Marco, V.
Tormo, M.
Gomez, V.
Andreu, R.
Xicoy, B.
Amigo, M. L.
Munoz, J. A.
Bonanad, S.
Arrizabalaga, B.
Senent, M. L.
Germing, U.
Sanz, G. F.
机构：
[1] Univ Gottingen, D-3400 Gottingen, Germany
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70110-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 50 条
  • [41] Molecular Cytogenetic Studies of Complex Chromosomal Aberrations in Myelodysplastic Syndromes (MDS)
    Zemanova, Z.
    Michalova, K.
    Brezinova, J.
    Lizcova, L.
    Izakova, S.
    Bystricka, D.
    Sarova, I.
    Siskova, M.
    Cerna, O.
    Cermak, J.
    CHROMOSOME RESEARCH, 2009, 17 : 131 - 131
  • [42] CORRELATIONS BETWEEN CYTOLOGICAL, CLINICAL AND CYTOGENETIC FINDINGS IN MYELODYSPLASTIC SYNDROMES (MDS)
    VILA, L
    TREILLERITOUET, D
    CHARRIN, C
    FRAISSE, J
    ARCHIMBAUD, E
    FIERE, D
    BLUT, 1988, 56 (06): : C10 - C10
  • [43] Cytogenetic study of 93 myelodysplastic syndromes
    Sole, F
    Woessner, S
    Florensa, L
    Perez-Losada, A
    Acin, P
    Besses, C
    Garcia-Eroles, L
    Sans-Sabrafen, J
    MEDICINA CLINICA, 1998, 110 (03): : 94 - 98
  • [44] Assessment of apoptosis in relation to single cytogenetic abnormalities in myelodysplastic syndromes (MDS).
    Mundle, S
    Hsu, WT
    Dutt, D
    Dar, S
    Saberwal, G
    Townsend, W
    Broderick, E
    Kaspar, C
    Alvi, S
    Shetty, V
    Allampallam, K
    Reddy, P
    Venugopal, P
    Gezer, S
    Lisak, L
    Raza, A
    BLOOD, 2001, 98 (11) : 191B - 191B
  • [45] Thrombocytopenia Predicts for Poor Survival In Patients with Lower Risk Myelodysplastic Syndromes (MDS)
    Cruz, Raymond
    Galili, Naomi
    Khan, Ghulam Sajjad
    Raza, Azra
    BLOOD, 2010, 116 (21) : 1638 - 1638
  • [46] Prognostic relevance of cytogenetic evolution and the influence of the clonal composition in patients with myelodysplastic syndromes
    Cevik, N.
    Haase, D.
    Schanz, J.
    ONKOLOGIE, 2013, 36 : 126 - 126
  • [47] EXTENDED CYTOGENETIC FOLLOW-UP AND CLINICAL-PROGRESS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    WHITE, AD
    HOY, TG
    JACOBS, A
    LEUKEMIA & LYMPHOMA, 1994, 12 (5-6) : 401 - 412
  • [48] EVALUATION OF COMORBIDITY AS PROGNOSTIC VARIABLE IN 419 PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A STUDY OF THE AUSTRIAN MDS WORKING GROUP
    Sperr, W. R.
    Wimazal, F.
    Kundi, M.
    Baumgartner, C.
    Noesslinger, T.
    Makrai, A.
    Stauder, R.
    Krieger, O.
    Pfeilstoecker, M.
    Valent, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 98 - 98
  • [49] CYTOGENETIC CATEGORIES OF MYELODYSPLASTIC SYNDROMES (MDS) ACCORDING TO REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM (R-IPSS)
    Gritsaev, S.
    Martinkevitch, I.
    Petrova, E.
    Kostroma, I.
    Ivanova, M.
    Martinenko, L.
    Sergeev, A.
    Abdukkadirov, K.
    HAEMATOLOGICA, 2012, 97 : 578 - 578
  • [50] A REGRESSION EQUATION FOR PREDICTING SURVIVAL IN MYELODYSPLASTIC SYNDROMES (MDS) - RESULTS OF A MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS IN 370 PATIENTS
    SANZ, GF
    VALLESPI, T
    CANIZO, MC
    SANZ, MA
    TORRABADELLA, M
    SANMIGUEL, J
    GARCIA, S
    IRRIGUIBLE, D
    BLUT, 1988, 56 (06): : C14 - C14
12345